RLIRLI Corpmarket cap n/a · FY ending 2025-12-31
76/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality83
margins & F-ScoreValue—
valuation vs its own rangeMomentum51
death · price above 200-daySmart Money94
buying · 1 funds · 6P/0S insidersMixed trendDeath crossAbove 200-day
vs S&P 500-7.8%
6-mo excess Trailing performance1M +13.9%
3M +6.0%
6M +0.8%
YTD -1.6%
1Y -13.1%
Not enough profitable-period data to value RLI on earnings.
Piotroski F6/9
fundamental strength ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 20%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio59.9%
comfortable Shareholder yield—
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net buying6P / 0S insiders · 1 funds hold · 0 Congress buys
Recent insidersKELLOGG CLARK C · DirectorBUY$152,700
Duclos David B. · DirectorBUY$129,975
Klobnak Jennifer L · CHIEF OPERATING OFFICERBUY$105,440
Kliethermes Craig W · CHIEF EXECUTIVE OFFICERBUY$104,000
Fund holders (13F)Markel Group (Tom Gayner)$136.6M1.1% of book
Bhealth · 77/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.